Name | 1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-, (4S) |
---|---|
Synonyms |
1-PYRROLIDINEACETAMIDE,4-HYDROXY-2-OXO-, (4S)-
(S)-2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide 2-[(4S)-4-hydroxy-2-oxopyrrolidin-1-yl]acetamide S-(-)-Oxiracetam oxiracetam 1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-, (S)- (S)-Oxiracetam 2-[(4R)-4-Hydroxy-2-oxo-1-pyrrolidinyl]acetamide (S)-4-Hydroxy-2-oxo-1-pyrrolidineacetamide 1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-, (4R)- |
Description | (S)-oxiracetam (S-ORC) is an inhibitor targeting apoptosis. S-ORC reduces brain infarct size and lessens neurological dysfunction in middle cerebral artery occlusion/reperfusion (MCAO/R) models. S-ORC prevents neuronal apoptosis via activating PI3K/Akt/GSK3β signaling pathway via α7 nAChR after ischemic stroke. S-ORC can prevent neuronal death after ischemic stroke[1]. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 494.6±40.0 °C at 760 mmHg |
Molecular Formula | C6H10N2O3 |
Molecular Weight | 158.16 |
Flash Point | 252.9±27.3 °C |
Exact Mass | 158.069138 |
PSA | 83.63000 |
LogP | -2.48 |
Vapour Pressure | 0.0±2.9 mmHg at 25°C |
Index of Refraction | 1.570 |